Drawing for NRS

USPTO serial 97896480

NRS

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
YOUNG, THOMAS PAUL
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with NRS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew O. Brady

Matthew O. Brady AbbVie Inc.2525 Dupont DriveMail Stop: AND-250CIrvine, CA 92612

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological and neuropsychological diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the field of neuroscienceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 4, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 29, 2026EXT5SOU EXTENSION 5 FILED—
Aug 29, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 6, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jul 6, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 6, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 14, 2026EX4GSOU EXTENSION 4 GRANTED—
Apr 13, 2026EXT4SOU EXTENSION 4 FILED—
Apr 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2025EX3GSOU EXTENSION 3 GRANTED—
Dec 15, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 20, 2025TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 20, 2025NREVNOTICE OF REVIVAL - E-MAILED—
Oct 20, 2025PETGPETITION TO REVIVE-GRANTED—
Oct 20, 2025PROATEAS PETITION TO REVIVE RECEIVED—
Oct 15, 2025EXT3SOU EXTENSION 3 FILED—
Apr 1, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 1, 2025EX2GSOU EXTENSION 2 GRANTED—
Mar 31, 2025EXT2SOU EXTENSION 2 FILED—
Mar 31, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 14, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 14, 2024EX1GSOU EXTENSION 1 GRANTED—
Oct 14, 2024EXT1SOU EXTENSION 1 FILED—
Oct 14, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 7, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 7, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 7, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 7, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 7, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 7, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 16, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 4, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 20, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 31, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 31, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 17, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 17, 2024DOCKASSIGNED TO EXAMINER—
May 15, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance